Lumily detects physiological patterns that precede clinical conditions — not diagnoses. Every capability is grounded in peer-reviewed research using the same wrist-worn sensor combinations Lumily deploys. Click any card to expand.
Overnight breathing pause detection via SpO₂ + PPG waveform + accelerometer respiratory effort proxy.
1–5%
of children affected
significantly underdiagnosed
Lumily screens using SpO₂ desaturation + PPG waveform morphology change + respiratory effort from accelerometer micro-movement. Real-time alert if respiratory signal near-zero ≥10 sec AND SpO₂ begins falling. Generates physician-ready AHI proxy report. Does not replace polysomnography.
CLICK TO EXPAND
Exertion-zone HR ceiling alerts for children with HCM, LQTS, POTS, WPW, and post-ablation monitoring.
700K+
diagnosed children
lifetime retention
For children already diagnosed with cardiac conditions, Lumily provides a continuous safety layer between quarterly cardiology appointments. Exertion HR ceiling alerts, HR recovery curve tracking, syncope precursor pattern (rapid HR drop + HRV destabilization). Grounded in 2024 HRS Expert Consensus on Arrhythmias in the Athlete.
CLICK TO EXPAND
Multi-signal convergence: 3+ sensors shifting simultaneously for 45+ min triggers Sepsis Watch alert.
500K
at-risk children/yr
hours matter
Convergence rule: IF HR >20% above baseline AND temp rising >0.5°C/hr AND RR elevated AND HRV suppressed AND movement reduced — all simultaneously, 45+ min. Validated against Barton Schmitt SIRS criteria and qSOFA pediatric adaptation.
CLICK TO EXPAND
Auto-activates when any fever resolves. 30-day elevated monitoring window for myocarditis risk.
40×
myocarditis increase
post-COVID exposure
When fever resolves, Lumily auto-activates 30-day Post-Viral Cardiac Watch across all tiers at no extra cost. Monitors elevated resting HR + HRV non-recovery + new rhythm irregularities. Includes return-to-sport protocol guidance based on HR and HRV recovery metrics.
CLICK TO EXPAND
Panic precursor alerts 2–5 minutes before peak distress. Chronic HRV suppression as anxiety biomarker.
83%
precision · 2025 JMIR
2–5 min lead time
2025 JMIR validated multimodal wearable models detecting HRV anomalies predictive of panic episodes with 83% precision, 2–5 minutes before peak distress. Opt-in only — especially robust privacy framework. Clinical advisory board psychologist required before launch.
CLICK TO EXPAND
Objective medication tracking — does HR change at expected timing? Does sleep architecture improve?
6M+
children on ADHD
medication in the US
JAMA Network Open (2023) validated wearable HR, HRV, and movement data can detect ADHD with high accuracy. The ADHD Bundle asks: Is the medication actually working? Prescriber-formatted monthly summary for the visit that typically runs on subjective parent report alone.
CLICK TO EXPAND
RR trending flags exacerbations 6–12 hours before the child reports difficulty breathing.
6–12h
early warning window
before visible symptoms
Elevated respiratory rate is one of the earliest measurable signs of asthma exacerbation. Lumily flags sustained RR elevation above personal baseline 6–12 hours before the child reports difficulty. SpO₂ early warning: <95% → amber; <93% → red. Clinical tier adds sealed microphone wheeze detection.
CLICK TO EXPAND
5–12 hours earlier fever detection versus standard thermometry. For chemotherapy-immunosuppressed children.
5–12h
earlier fever detection
Pediatric Blood Cancer 2022
Pediatric Blood Cancer (2022): wearable continuous temperature monitoring detected fever 5–12 hours earlier than standard oral thermometry, enabling earlier antibiotic initiation. Clinical tier only. Lower threshold (38.0°C), immediate care team routing, chemo cycle awareness window. ~16K new pediatric cancer diagnoses/yr.
CLICK TO EXPAND
Continuous cough logging via sealed microphone. Pulmonary exacerbation early warning system.
30K
US pediatric CF patients
Clinical tier · B2B
2024 IEEE / Lurie Children's Hospital study validated that continuous acoustic monitoring provides meaningful clinical data on CF disease progression. Sealed microphone enables continuous cough detection — frequency, duration, and character across day and overnight. Catching exacerbations early dramatically changes treatment outcomes.
CLICK TO EXPAND
Motor control impairment affects the ability to localize and communicate pain. NDI provides what speech cannot.
764K
US children with CP
most common motor disability
CP affects 1 in 323 children. Spastic, dyskinetic, and ataxic forms all impair communication to varying degrees. Children with CP cannot reliably describe pain location, intensity, or character. Lumily's NDI provides the autonomic stress signal that speech cannot — continuous EDA, HR elevation, and movement suppression analysis calibrated to each child's unique motor baseline.
CLICK TO EXPAND
Near-complete absence of speech. Children often show altered pain perception that masks serious illness until crisis.
500K
worldwide · 1 in 12–20K
minimal verbal communication
Angelman syndrome is characterized by minimal verbal communication, frequent seizures, and altered pain perception. These children cannot tell anyone they're sick. Lumily's combination of seizure-pattern proxy (gyroscope), EDA stress detection, HR elevation, and temperature convergence gives caregivers what nothing else can — a real-time physiological picture of a child who will never be able to say "something hurts."
CLICK TO EXPAND
Progressive loss of purposeful hand use and communication. NDI value compounds as the condition progresses.
1 in 10K
girls affected
communication progressively lost
Rett syndrome is almost exclusively a female diagnosis. The hallmark is regression — a child who had developing speech and motor skills loses them. Lumily's value compounds as the condition progresses. As verbal communication is lost, the NDI becomes the primary window into this child's physiological state. Per-child calibration means Lumily adapts as the child's baseline changes through Rett's stages.
CLICK TO EXPAND
